ASTEX THERAPEUTICS LIMITEDActive
Key figures
ASTEX THERAPEUTICS LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025Balance sheet structure
Filed accounts2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Turnover | 92,355,171 | 117,178,479 | 202,455,603 | 276,803,907 | — |
| Profit for the year | 39,867,658 | 65,726,357 | 122,000,313 | 189,226,912 | 283,380,911 |
| Cash at bank and in hand | 32,385,438 | — | 75,794,372 | — | — |
| Total assets | 105,430,573 | — | 138,795,915 | 208,383,301 | 177,761,391 |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | 73,305,736 | 89,032,093 | 136,032,406 | 200,259,318 | 163,640,229 |
| Average number of employees | 156 | 157 | 166 | 173 | 2 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The company's principal activity continues to be fragment-based drug discovery using a range of high-throughput biophysical and computational techniques, including x-ray crystallography
As described in the company's latest filed accounts.
Summary: ASTEX THERAPEUTICS LIMITED
Company
ASTEX THERAPEUTICS LIMITED is a private limited company registered with Companies House under company number 03751674. It was incorporated on 14 Apr 1999. Its status is active. The registered office is in Cambridge (CB4). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files full accounts. Profit for the year was £283,380,911. Net assets were £163,640,229, down 18.3% on the previous year. The company had an average of 2 employees. Figures are available for 6 financial years (2020–2025).
Control and charges
The company has 6 current directors. One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 16 May 2027.